BLINAtumomab After R-CHOP Debulking Therapy for Patients With Richter Transformation

NCT03931642 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Richter Syndrome

Interventions

DRUG: RCHOP
DRUG: Blinatumomab

Sponsor

French Innovative Leukemia Organisation

Collaborators

[object Object]